会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明授权
    • Indicator for iontophoresis system
    • 离子电渗系统指示剂
    • US5445606A
    • 1995-08-29
    • US69061
    • 1993-05-28
    • Ronald P. HaakFelix TheeuwesDavid K. Roe
    • Ronald P. HaakFelix TheeuwesDavid K. Roe
    • A61N1/30A61N1/32
    • A61N1/0448A61N1/325A61N1/0436A61N1/044
    • Apparatus (11) for delivery of a medicament, drug or other therapeutic agent transdermally to a body by iontophoresis is provided. The apparatus (11) provides a means (13) for measuring and displaying the cumulative amount of the medicament delivered to the body by monitoring the amount of a metal, initially present at the anode (45), that is transferred to the cathode (41) in a subsidiary electrolyte cell (47) through which the drive current for the apparatus (11) passes. Optionally, the apparatus also provides a plurality of light emitting devices (63-1) that display a measure of the cumulative amount of medicament delivered, by use of visually distinguishable light colors or by use of binary encoding in the light display.
    • 提供了用于通过离子电渗法将药物,药物或其它治疗剂透皮地递送到身体的装置(11)。 装置(11)提供了一种装置(13),用于通过监测最初存在于阳极(45)的金属的量来测量和显示递送到身体的药物的累积量,该金属的量转移到阴极(41) )连接在辅助电解质电池(47)中,用于装置(11)的驱动电流通过该辅助电解质电池(47)。 可选地,该装置还提供多个发光装置(63-1),其通过使用视觉上可区分的光色或通过在光显示器中使用二进制编码来显示传送的药物的累积量的量度。
    • 2. 发明授权
    • Indicator for iontophoresis system
    • 指示系统
    • US5246417A
    • 1993-09-21
    • US806055
    • 1991-12-11
    • Ronald P. HaakFelix TheeuwesDavid K. Roe
    • Ronald P. HaakFelix TheeuwesDavid K. Roe
    • A61N1/30A61N1/32
    • A61N1/0448A61N1/325A61N1/0436A61N1/044
    • Apparatus (11) for delivery of a medicament, drug or other therapeutic agent transdermally to a body by iontophoresis is provided. The apparatus (11) provides a means (13) for measuring and displaying the cumulative amount of the medicament delivered to the body by monitoring the amount of a metal, initially present at the anode (45), that is transferred to the cathode (41) in a subsidiary electrolyte cell (47) through which the drive current for the apparatus (11) passes. Optionally, the apparatus also provides a plurality of light emitting devices (63-1) that display a measure of the cumulative amount of medicament delivered, by use of visually distinguishable light colors or by use of binary encoding in the light display.
    • 提供了用于通过离子电渗法将药物,药物或其它治疗剂透皮地递送到身体的装置(11)。 装置(11)提供了一种装置(13),用于通过监测最初存在于阳极(45)的金属的量来测量和显示递送到身体的药物的累积量,该金属的量转移到阴极(41) )连接在辅助电解质电池(47)中,用于装置(11)的驱动电流通过该辅助电解质电池(47)。 可选地,该装置还提供多个发光装置(63-1),其通过使用视觉上可区分的光色或通过在光显示器中使用二进制编码来显示传送的药物的累积量的量度。
    • 5. 发明授权
    • Transdermal delivery device
    • 超传送装置
    • US5203768A
    • 1993-04-20
    • US735126
    • 1991-07-24
    • Ronald P. HaakFelix TheeuwesJ. Richard Gyory
    • Ronald P. HaakFelix TheeuwesJ. Richard Gyory
    • A61K9/00A61N1/30
    • A61N1/0448A61K9/0009A61N1/0436A61N1/044A61N1/0444
    • A transdermal drug delivery device (20) is provided having both an active drug reservoir (24) and a passive drug reservoir (26). Drug is actively delivered by iontophoresis from the active drug reservoir (24) by an electric field generated by a power source (21). Simultaneously, drug is delivered from passive reservoir (26) by passive (i.e., non-electrically assisted) diffusion. In one embodiment, the passive drug reservoir (26) is electrically insulated from the active drug reservoir (24). In a second embodiment, both the active and the passive drug are contained in the same reservoir (34). In the second embodiment, the active drug is ionizable while the passive drug is non-ionizable. Most preferably, the active drug is an ionizable form (i.e., a salt form) of the passive drug.
    • 提供具有活性药物储存器(24)和被动药物储存器(26)的透皮药物递送装置(20)。 药物通过离子电渗从活性药物储存器(24)通过由电源(21)产生的电场积极递送。 同时,药物通过被动(即非电辅助)扩散从被动储存器(26)输送。 在一个实施例中,被动药物储存器(26)与活性药物贮存器(24)电绝缘。 在第二实施方案中,活性和被动药物都包含在相同的储存器(34)中。 在第二实施方案中,活性药物是可离子化的,而被动药物是不可离子化的。 最优选地,活性药物是被动药物的可离子化形式(即盐形式)。